[ad_1]
The European Medicines Agency (EMA) has given a conditional green light to the Pfizer-BioNTech anti-Covid vaccine. Ema communicates it.
Speaking of the English variant and concerns about developed vaccines, experts agree: “There have already been variations in the recent past and there may also be others. At present this does not mean an aggravation of the disease or lethality and, above all, the vaccine is not questioned ”. Thus, the medical director of Spallanzani in Rome, Francesco Vaia, was interviewed by Tg2.
Regarding the resistance to the Gb variant vaccine that emerged in the United Kingdom “I consider it very unlikely”. The president of the Higher Health Council, Franco Locatelli, told Buongiorno, in Sky TG24: “Vaccines – he specified – determine the formation of an immune response against various ‘pieces’, let’s call them, of the peak protein. ‘is a mutation in one, two or three’ bits’ of the peak protein, it is very unlikely that the vaccine will be ineffective. “
The decision of Ema, the European Pharmacological Authority, on the approval of the vaccine “should come even today, at least this is the forecast, except that Ema has all the power to fully evaluate, with the time you need, all the documentation received “Locatelli added.” If, as expected and desirable, “Locatelli added,” Ema’s approval is obtained, the vaccine will be sent to all countries and will probably arrive in Italy on December 26. This great day will be symbolic 27. the day of the vaccination. After the 27th, around the 30th or at the latest in the first days of January, the real vaccination campaign will begin that will affect the health workers and workers and guests of the RSA, because the latter are they are among those most at risk of developing fatal complications from infection. “
REPRODUCTION RESERVED © Copyright ANSA
